Timber Pharmaceuticals, Inc.
TMBR · AMEX
12/31/2022 | 12/31/2021 | 12/31/2020 | 1/31/2020 | |
|---|---|---|---|---|
| Market Cap | $307 | $1,278 | $973 | $2,820 |
| - Cash | $9,080 | $16,809 | $10,349 | $57 |
| + Debt | $331 | $702 | $835 | $0 |
| Enterprise Value | -$8,442 | -$14,829 | -$8,540 | $2,763 |
| Revenue | $83 | $296 | $454 | $325 |
| % Growth | -71.9% | -34.8% | 39.8% | – |
| Gross Profit | -$13,219 | -$5,854 | -$1,047 | -$3,058 |
| % Margin | -15,892.4% | -1,979.4% | -230.8% | -942% |
| EBITDA | -$19,158 | -$10,377 | -$17,777 | -$46 |
| % Margin | -23,032.8% | -3,509% | -3,917.3% | -14% |
| Net Income | -$19,379 | -$10,639 | -$15,118 | -$3,690 |
| % Margin | -23,299% | -3,597.5% | -3,331.3% | -1,136.7% |
| EPS Diluted | -9.19 | -13.15 | -48.15 | -29.31 |
| % Growth | 30.1% | 72.7% | -64.3% | – |
| Operating Cash Flow | -$15,855 | -$9,314 | -$8,293 | -$1,228 |
| Capital Expenditures | -$7 | -$18 | -$750 | $0 |
| Free Cash Flow | -$15,862 | -$9,332 | -$9,043 | -$1,228 |